85.54
price up icon0.85%   0.72
after-market アフターアワーズ: 85.54
loading
前日終値:
$84.82
開ける:
$84.26
24時間の取引高:
668.69K
Relative Volume:
0.77
時価総額:
$3.89B
収益:
$1.33B
当期純損益:
$97.31M
株価収益率:
42.10
EPS:
2.0317
ネットキャッシュフロー:
$260.44M
1週間 パフォーマンス:
+8.58%
1か月 パフォーマンス:
+14.05%
6か月 パフォーマンス:
+28.32%
1年 パフォーマンス:
+15.53%
1日の値動き範囲:
Value
$82.75
$85.61
1週間の範囲:
Value
$79.35
$85.71
52週間の値動き範囲:
Value
$47.31
$87.32

Haemonetics Corp Stock (HAE) Company Profile

Name
名前
Haemonetics Corp
Name
セクター
Healthcare (1079)
Name
電話
(781) 848-7100
Name
住所
125 SUMMER STREET, BOSTON, MA
Name
職員
3,009
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
HAE's Discussions on Twitter

Compare HAE vs ABT, SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
HAE icon
HAE
Haemonetics Corp
85.58 3.63B 1.33B 97.31M 260.44M 2.0317
ABT icon
ABT
Abbott Laboratories
105.74 182.00B 46.59B 5.41B 7.38B 3.0938
SYK icon
SYK
Stryker Corp
325.74 129.09B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
85.40 107.81B 36.36B 4.84B 5.43B 3.7261
BSX icon
BSX
Boston Scientific Corp
46.73 67.64B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
86.03 47.81B 6.30B 1.07B 1.09B 1.8406

Haemonetics Corp Stock (HAE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-15 ダウングレード Needham Buy → Hold
2025-12-11 ダウングレード Citigroup Buy → Neutral
2025-08-11 ダウングレード Raymond James Strong Buy → Outperform
2025-08-08 繰り返されました Barrington Research Outperform
2025-08-08 ダウングレード JP Morgan Overweight → Neutral
2025-07-09 アップグレード Citigroup Neutral → Buy
2025-06-26 開始されました Robert W. Baird Outperform
2025-02-07 ダウングレード BofA Securities Neutral → Underperform
2024-12-06 開始されました JP Morgan Overweight
2024-11-08 アップグレード Raymond James Outperform → Strong Buy
2024-09-13 開始されました CL King Buy
2024-09-11 開始されました BofA Securities Neutral
2024-09-10 開始されました BTIG Research Buy
2024-06-12 アップグレード Needham Hold → Buy
2022-10-13 開始されました Mizuho Buy
2022-01-27 ダウングレード Needham Buy → Hold
2021-12-15 ダウングレード Citigroup Buy → Neutral
2021-08-17 再開されました Raymond James Outperform
2021-06-17 開始されました Citigroup Buy
2021-05-14 アップグレード CJS Securities Market Perform → Market Outperform
2021-04-20 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-04-19 ダウングレード CJS Securities Market Outperform → Market Perform
2021-02-03 アップグレード Barrington Research Mkt Perform → Outperform
2021-01-21 ダウングレード Barrington Research Outperform → Mkt Perform
2020-11-05 アップグレード Barrington Research Mkt Perform → Outperform
2020-05-06 ダウングレード Barrington Research Outperform → Mkt Perform
2020-03-31 アップグレード CJS Securities Market Perform → Market Outperform
2020-01-10 開始されました Needham Buy
2019-08-07 繰り返されました Barrington Research Outperform
2019-05-14 アップグレード Raymond James Mkt Perform → Outperform
2019-05-08 繰り返されました Barrington Research Outperform
2018-08-09 繰り返されました Barrington Research Outperform
2018-02-07 繰り返されました Barrington Research Outperform
2018-01-02 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-11-08 繰り返されました Barrington Research Outperform
2017-08-08 アップグレード Barrington Research Mkt Perform → Outperform
2017-07-13 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2017-02-07 ダウングレード Barrington Research Outperform → Mkt Perform
2016-11-08 アップグレード Barrington Research Mkt Perform → Outperform
2016-11-07 繰り返されました The Benchmark Company Hold
2016-09-20 ダウングレード CJS Securities Market Outperform → Market Perform
2016-08-15 ダウングレード Sidoti Buy → Neutral
2016-08-02 繰り返されました Jefferies Buy
2016-08-02 繰り返されました The Benchmark Company Hold
すべてを表示

Haemonetics Corp (HAE) 最新ニュース

pulisher
Jul 28, 2026

Haemonetics Corp (HAE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 28, 2026
pulisher
Jul 27, 2026

Haemonetics Corp (HAE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Haemonetics Corp (HAE) Income Statement - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Haemonetics Corp (HAE) Balance Sheet - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

HAE|Haemonetics Corp|Price:80.480|Chg%:+1.700 - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

Haemonetics Corp (HAE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

Haemonetics Corp (HAE) Institutional Confidence - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Haemonetics Corp (HAE) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Haemonetics Corp (HAE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Haemonetics Corp (HAE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

HAE|Haemonetics Corp|Price:78.650| - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Haemonetics Corporation (HAE) Stock Forecasts - Yahoo! Finance Canada

Jul 24, 2026
pulisher
Jul 24, 2026

Global Apheresis Market to Reach USD 4.41 Billion by 2031, Driven by Plasma-Based Therapies and Automated Technologies - GlobeNewswire Inc.

Jul 24, 2026
pulisher
Jul 24, 2026

HAE|Haemonetics Corp|Price:79.980|Chg%:+1.200 - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Haemonetics Corp (HAE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 24, 2026
pulisher
Jul 22, 2026

Haemonetics (HAE) Q4 2026 Earnings ReportResults, Call & Slides - TipRanks

Jul 22, 2026
pulisher
Jul 20, 2026

Haemonetics stock trades steadily as recent earnings highlight blood management growth - Ad-hoc-news.de

Jul 20, 2026
pulisher
Jul 19, 2026

Haemonetics stock trades steadily as revenue and earnings grow - Ad-hoc-news.de

Jul 19, 2026
pulisher
Jul 18, 2026

Haemonetics (HAE) Could Be 10% Undervalued On Its Margin Expansion Story - simplywall.st

Jul 18, 2026
pulisher
Jul 16, 2026

Mizuho Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $90 - 富途牛牛

Jul 16, 2026
pulisher
Jul 15, 2026

HAE Maintained by Mizuho -- Price Target Raised to $90 - GuruFocus

Jul 15, 2026
pulisher
Jul 14, 2026

Is Haemonetics Corp (HAE) a Bargain After 3.2% Drop? GF Value Sa - GuruFocus

Jul 14, 2026
pulisher
Jul 13, 2026

HAE5817431 Bond Profile — Key Metrics - TradingView

Jul 13, 2026
pulisher
Jul 10, 2026

Haemonetics (HAE) Joins Russell Indexes As Investors Ask If The Stock Is Still Undervalued - simplywall.st

Jul 10, 2026
pulisher
Jul 10, 2026

HAE stock steadies as Haemonetics focuses on blood and plasma - Ad-hoc-news.de

Jul 10, 2026
pulisher
Jul 09, 2026

HAE stock holds steady as investors track Haemonetics' product mix - Ad-hoc-news.de

Jul 09, 2026
pulisher
Jul 09, 2026

Citi Maintains Haemonetics(HAE.US) With Hold Rating, Maintains Target Price $79 - 富途牛牛

Jul 09, 2026
pulisher
Jul 08, 2026

Haemonetics sets Aug. 6 call for Q1 2027 results - Stock Titan

Jul 08, 2026
pulisher
Jul 08, 2026

Haemonetics (HAE) Analyst Adjusts Price Target Despite Neutral R - GuruFocus

Jul 08, 2026
pulisher
Jul 06, 2026

Haemonetics Corp updates investors on blood management business. Operational focus supports long-ter - Ad-hoc-news.de

Jul 06, 2026
pulisher
Jul 03, 2026

Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now? - Yahoo Finance

Jul 03, 2026
pulisher
Jun 29, 2026

Haemonetics Corporation's $210 Million Cash Flow: Is The Transition Working? - Smartkarma

Jun 29, 2026
pulisher
Jun 29, 2026

Daily Brief Health Care: Bausch Health Companies, Biodexa Pharmaceuticals, Fortrea Holdings , Haemonetics Corp, Legend Biotech Corp and more - Smartkarma

Jun 29, 2026
pulisher
Jun 29, 2026

Haemonetics Corp updates plasma strategy, shares tracked against U.S. medtech peers - Ad-hoc-news.de

Jun 29, 2026
pulisher
Jun 29, 2026

Haemonetics’ Broad Russell Value Index Inclusion Might Change The Case For Investing In Haemonetics (HAE) - simplywall.st

Jun 29, 2026
pulisher
Jun 26, 2026

HAE Reiterated by BTIG -- Price Target Maintained at $84 - GuruFocus

Jun 26, 2026
pulisher
Jun 26, 2026

BTIG Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $84 - 富途牛牛

Jun 26, 2026
pulisher
Jun 25, 2026

Haemonetics Corp (HAE) Stock Up 6.5% and Still Undervalued -- GF Score: 84/100 - GuruFocus

Jun 25, 2026
pulisher
Jun 18, 2026

Mizuho Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $85 - 富途牛牛

Jun 18, 2026
pulisher
Jun 17, 2026

Quietly ambitious, Haemonetics NexSys PCS pushes plasma efficiency further - AD HOC NEWS

Jun 17, 2026
pulisher
Jun 17, 2026

Why Haemonetics’ NexSys PCS quietly reshapes plasma collection on the clinic floor - AD HOC NEWS

Jun 17, 2026
pulisher
Jun 17, 2026

Haemonetics Corp (HAE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Loomis Sayles Small Cap Core Portfolio's Haemonetics Corp(HAE) Holding History - GuruFocus

Jun 17, 2026
pulisher
Jun 17, 2026

HAE Reiterated by BTIG -- Price Target Maintained at $84.00 - GuruFocus

Jun 17, 2026
pulisher
Jun 16, 2026

Haemonetics Corp (HAE) Shares Fall 3.2% -- What GF Score of 77 T - GuruFocus

Jun 16, 2026
pulisher
Jun 16, 2026

HAE: Upcoming Virtual Meeting Scheduled for June 24 - GuruFocus

Jun 16, 2026
pulisher
Jun 15, 2026

HAE Maintained by Mizuho -- Price Target Raised to $85.00 - GuruFocus

Jun 15, 2026
pulisher
Jun 15, 2026

Mizuho raises Haemonetics stock price target to $85 on plasma demand - Investing.com UK

Jun 15, 2026
pulisher
Jun 12, 2026

HAE SEC FilingsHaemonetics Corp Mass 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 12, 2026
pulisher
Jun 11, 2026

Is Haemonetics’ (HAE) Apheresis Reorg Quietly Redefining Its Competitive Edge in Medical Devices? - simplywall.st

Jun 11, 2026

Haemonetics Corp (HAE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
ZBH ZBH
$93.97
price down icon 1.04%
STE STE
$228.41
price down icon 1.19%
PHG PHG
$26.30
price down icon 0.53%
$68.02
price down icon 2.75%
$83.45
price up icon 11.95%
EW EW
$86.03
price down icon 1.02%
大文字化:     |  ボリューム (24 時間):